PDpoetin (epoetin alfa biosimilar) / Pooyesh Darou - LARVOL DELTA

Drug Utilization Evaluation of Erythropoietin at a Referral Teaching Hospital in Iran. (PubMed, Adv Pharmacol Pharm Sci) - "PDpoetin® and Cinnapoietin® were given to 52.6% and 47.4% of the study participants, respectively. The sum indexes of erythropoietin use were in line with standard guidelines in 75.84% of the cases. According to our results, in the setting of erythropoietin use in hospitals, physicians need more attention and education in areas such as selecting the proper dose of medication, correct indication of the drug, temporal arrangement of monitoring laboratory items, and the patient's need for iron supplements."

Journal • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease